Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Gourraud

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Tissue Antigens|December 25, 2009
The Babel Tower revisited: SNPs - Indels - CNVs. Confusion in naming sequence variant always rises from ashesP A Gourraud, M Feolo
Immunogenetics|January 4, 2007
KIR haplotype content at the allele level in 77 Northern Irish familiesD Middleton, A Meenagh, P A Gourraud
The British Journal of Dermatology|August 18, 2009
CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journalsF Alvarez, N Meyer, P A Gourraud, et al.
Revue Neurologique|April 4, 2026
The genetic architecture of multiple sclerosis in 2026: From susceptibility to disease progressionS Bourguiba-Hachemi, J Paris, P-A Gourraud, et al.
BMC Medical Genomics|July 11, 2021
Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regionsD S Goodin, P Khankhanian, P A Gourraud, et al.
Tissue Antigens|April 21, 2007
14th International HLA and Immunogenetics Workshop: report on mapping microsatellite markers in the major histocompatibility complex regionP-A Gourraud, D Hoffman, A Cambon-Thomsen, et al.
Tissue Antigens|May 5, 2006
The dbMHC microsatellite portal: a public resource for the storage and display of MHC microsatellite informationP-A Gourraud, M Feolo, D Hoffman, et al.
Revue Neurologique|May 21, 2024
Clinical applications of deep learning in neuroinflammatory diseases: A scoping reviewS Demuth, J Paris, I Faddeenkov, et al.
Tissue Antigens|June 5, 2009
Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemiaD Middleton, A S Diler, A Meenagh, et al.
Tissue Antigens|April 21, 2007
Preliminary analysis of a KIR haplotype estimation algorithm: a simulation studyP A Gourraud, K Gagne, J D Bignon, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Tissue Antigens|December 25, 2009
The Babel Tower revisited: SNPs - Indels - CNVs. Confusion in naming sequence variant always rises from ashesP A Gourraud, M Feolo
Immunogenetics|January 4, 2007
KIR haplotype content at the allele level in 77 Northern Irish familiesD Middleton, A Meenagh, P A Gourraud
The British Journal of Dermatology|August 18, 2009
CONSORT adoption and quality of reporting of randomized controlled trials: a systematic analysis in two dermatology journalsF Alvarez, N Meyer, P A Gourraud, et al.
Revue Neurologique|April 4, 2026
The genetic architecture of multiple sclerosis in 2026: From susceptibility to disease progressionS Bourguiba-Hachemi, J Paris, P-A Gourraud, et al.
BMC Medical Genomics|July 11, 2021
Genetic susceptibility to multiple sclerosis: interactions between conserved extended haplotypes of the MHC and other susceptibility regionsD S Goodin, P Khankhanian, P A Gourraud, et al.
Tissue Antigens|April 21, 2007
14th International HLA and Immunogenetics Workshop: report on mapping microsatellite markers in the major histocompatibility complex regionP-A Gourraud, D Hoffman, A Cambon-Thomsen, et al.
Tissue Antigens|May 5, 2006
The dbMHC microsatellite portal: a public resource for the storage and display of MHC microsatellite informationP-A Gourraud, M Feolo, D Hoffman, et al.
Revue Neurologique|May 21, 2024
Clinical applications of deep learning in neuroinflammatory diseases: A scoping reviewS Demuth, J Paris, I Faddeenkov, et al.
Tissue Antigens|June 5, 2009
Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemiaD Middleton, A S Diler, A Meenagh, et al.
Tissue Antigens|April 21, 2007
Preliminary analysis of a KIR haplotype estimation algorithm: a simulation studyP A Gourraud, K Gagne, J D Bignon, et al.
Pageof 5